NasdaqCM:IMUXBiotechs
A Look At Immunic (IMUX) Valuation As Reverse Split Proposal And Conference Appearance Draw Attention
Immunic (IMUX) is back on investors’ radar after proposing a reverse stock split ahead of an April 14 special shareholder meeting, while management prepares to speak at the Leerink Global Healthcare Conference on March 11.
See our latest analysis for Immunic.
Those recent corporate updates have come alongside sharp share price moves, with a 1 day share price return of 12.4% and a 30 day share price return of 103.08% contributing to a year to date share price return of 148.71%. However, the 5...